Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Nexus Pharmaceuticals Announces Launch of Potassium Chloride in Water for Injection
Tuesday, July 27, 2021Nexus Pharmaceuticals announced the launch of Potassium Chloride in Water for Injection in mEqmL mEqmL and mEqmL SingleDose IV bags Nexus is proud to introduce Potassium Chloride IV Bags to our suite of products said Usman Ahmed Chief Operating Offic...
ImaginAb announces extension of long-standing partnership with Boehringer Ingelheim
Monday, July 26, 2021ImaginAb Inc a market leading global biotechnology company focused on developing next generation immuno oncology imaging agents and therapeutic radiopharmaceuticals RPT today announced the signing of a new significant multiyear nonexclusive license a...
Sun Pharma and Cassiopea SpA Announce Signing of License and Supply Agreements for Winlevi® (clascoterone cream 1%) in US and Canada
Monday, July 26, 2021Sun Pharmaceutical Industries Ltd Sun Pharma and includes its subsidiaries andor associate companies and Cassiopea SpA a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action MOA...
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain
Friday, July 23, 2021Acorda Therapeutics Inc today announced that it has entered into distribution and supply agreements with Esteve Pharmaceuticals SA ESTEVE to commercialize INBRIJA mg levodopa inhalation powder hard capsules in Spain INBRIJA is indicated in the EU fo...
Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings
Friday, July 23, 2021Pfizer Inc announced today that the US Food and Drug Administration FDA has notified the company that it will not meet the Prescription Drug User Fee Act PDUFA goal dates for the New Drug Application for abrocitinib for the treatment of adults and ad...
Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
Thursday, July 22, 2021Pfizer Inc and BioNTech SE announced the signing of a letter of intent with The Biovac Institute Pty Ltd known as Biovac a Cape Townbased South African biopharmaceutical company to manufacture the PfizerBioNTech COVID Vaccine for distribution within...
LEXEO Therapeutics Expands Cardiac Gene Therapy Pipeline with Acquisition of Stelios Therapeutics
Thursday, July 22, 2021LEXEO Therapeutics a fully integrated clinicalstage gene therapy company advancing diseasemodifying treatments for genetic conditions today announced that it has acquired Stelios Therapeutics an earlystage company developing novel adenoassociated vir...
RxCelerate Establishes Venture Capital Division and Makes First Investment in US Metabolic Disease Company
Wednesday, July 21, 2021RxCelerate a leading international outsourced drug discovery and development platform announced today that it has established a venture capital fund RxCapital to invest in companies developing new therapeutics for significant unmet medical needs RxCe...
Relmada Therapeutics Announces the Acquisition of Development and Commercial Rights to Novel Psilocybin and Derivates Program from Arbormentis LLC
Wednesday, July 21, 2021Relmada Therapeutics Inc a latestage biotechnology company addressing diseases of the central nervous system CNS today announced the acquisition of development and commercial rights to a novel psilocybin and derivate program from Arbormentis LLC in a...
BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson’s Disease
Tuesday, July 20, 2021BlueRock Therapeutics LP a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG announced that the US Food and Drug Administration FDA has granted Fast Track designation for DA for advanced Parkinsons disease PD DA BlueRoc...
